Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: A preliminary association study in russian population

Journal of Asthma

Volumn 46, Issue 5, 2009, Pages 523-528

  Polonikov, A V ^a   Solodilova, M A ^a   Ivanov, V P ^a  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Asthma; Genetic polymorphism; Genetic predisposition to disease; Myeloperoxidase; Oxidative stress

Indexed keywords

MESSENGER RNA; MYELOPEROXIDASE; PEROXIDASE;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RUSSIAN FEDERATION; ASTHMA; GENETIC PREDISPOSITION; GENETICS; IMMEDIATE TYPE HYPERSENSITIVITY; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; PEROXIDASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; RUSSIA; YOUNG ADULT;

EID: 67650284546     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902818389     Document Type: Article

References (36)

1. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006; 533:222-239.
2. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, McCann SE, Trevisan M, Cassano PA, Iacoviello L, Schunemann HJ. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 2006; 60:991-999.
3. Polonikov AV, Ivanov VP, Solodilova MA, Khoroshaya IV, Kozhuhov MA, Panfilov VI. The relationship between polymorphisms in the glutamate cysteine ligase gene and asthma susceptibility. Respir Med 2007; 101:2422-2424.
4. Solodilova MA, Ivanov VP, Polonikov AV, Khoroshaya IV, Kozhuhov MA, Panfilov VI. Heterozygosity of 198Leu mutant allele in glutathione peroxidase-1 gene as a risk factor of bronchial asthma associated with smoking. Ter Arkh 2007; 79:33-36.
5. Polonikov AV, Ivanov VP, Solodilova MA, Kozhuhov MA, Panfilov VI. Tobacco smoking, fruit and vegetable intake modify association between -21A > T polymorphism of catalase gene and risk of bronchial asthma. J Asthma 2009; 46:217-224.
6. Ivanov VP, Solodilova MA, Polonikov AV, Khoroshaya IV, Kozhuhov M, Panfilov VI. Association analysis of C242T and A640G polymorphisms in the gene for p22phox subunit of NADPH oxidase with the risk of bronchial asthma: a pilot study. Rus J Genet 2008; 44:601-608.
7. Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, Noack D, Rae J, Winkelstein JA, Curnutte JT, Chanock SJ. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Investig 1998; 102:2146- 2155.
8. Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990; 14:447-454.
9. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980; 93:480-489.
10. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford University Press Inc., New York, 2007.
11. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160:1532-1539.
12. Lenander-Lumikari M, Laurikainen K, Kuusisto P, Vilja P. Stimulated salivary flow rate and composition in asthmatic and non-asthmatic adults. Arch Oral Biol 1998; 43:151-156.
13. Frangova V, Sacco O, Silvestri M, Oddera S, Balbo A, Crimi E, Rossi GA. BAL neutrophilia in asthmatic patients. A by-product of eosinophil recruitment? Chest 1996; 110:1236-1242.
14. Barbato A, Panizzolo C, Gheno M, Sainati L, Favero E, Faggian D, Giusti F, Pesscolderungg L, La Rosa M. Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma. Pediatr Allergy Immunol 2001; 12:73-77.
15. Ekmekci OB, Donma O, Sardogan E, Yildirim N, Uysal O, Demirel H, Demir T. Iron, nitric oxide, and myeloperoxidase in asthmatic patients. Biochemistry (Mosc) 2004; 69:462-467.
16. Little SA, MacLeod KJ, Chalmers GW, Love JG, McSharry C. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 2002; 112:446-452.
17. Piedrafita J, Molander RB, Vansant GG, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271:14412-14420.
18. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 1997; 90:2730-2737.
19. Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C, Coles B, Trovato A. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 2005; 65:1105-1111.
20. Van Schooten FJ, Boots AW, Knaapen AM, Godschalk RW, Maas LM, Borm PJ, Drent M, Jacobs JA. Myeloperoxidase (MPO) -463G→ A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 2004; 13:828-833.
21. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57:5001-5003.
22. Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 2006; 27:2491-2496.
23. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, Onda H, Tajima K. Possible risk reduction in esophageal cancer associated with MPO -463 A allele. J Epidemiol 2001; 11:109-114.
24. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Josephy PD, Ambrosone CB. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004; 64:7634-7639.
25. Crawford FC, Freeman MJ, Schinka JA, Morris MD, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ. Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp Neurol 2001; 167:456-459.
26. Nikpoor B, Turecki G, Fournier C, Théroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001; 142:336-339.
27. Schabath MB, Spitz MR., Zhang X, Delcros GL, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis (Lond) 2000; 21:1163-1166.
28. Cascorbi I, Henning S, Brockmuller J, Gephart J, Meisel C, Muller JM, Loddenkemper R, Roots I. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -G463A of the myeloperoxidase gene. Cancer Res 2000; 60:644-649.
29. Le Marchand L, Seifried A, Lunn A, Wilkens LR. Association of the myeloperoxidase -463GA polymorphism with lung cancer risk. Cancer Epidemiol Biomark Prev 2000; 9:181-184.
30. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum. Genet 2006; 78: 15-27.
31. Pattison DI, Davies MJ. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem 2006; 13:3271-3290.
32. Ramsey CD, Celedon JC. The hygiene hypothesis and asthma. Curr Opin Pulm Med 2005; 11:14-20.
33. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983;128:833-838.
34. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003; 35:213-225.
35. Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T, Smith RA, Nelson JR, Reynolds WF. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997; 78:97-107. 36. Mallet WG, Mosebrook DR, Trush MA. Activation of (±) trans-7, 8-dihydroxy-7, 8-dihydrobenzo-[a]-pyrene to diolepoxides by human poly-morphonuclear leucocytes or myeloperoxidase. Carcinogenesis (Lond) 1991; 12:521-524.
36. Petruska JM, Mosebrook DR, Jakab GJ, Trush MA. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992; 13:1075-1108.